Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo ® Tablets.

Kazuo MishimaKenichi FujimotoAkira EndoMika Ishii

Published in: Drugs in R&D (2024)

Based on the results of this study, the safety result was consistent with the safety profile described in the current package insert. Efficacy results also indicated that LEM is clinically useful.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
sleep quality
depressive symptoms
patient reported